Live feed
Filing
SC 13D
SC 13D0000950142-21-001848·Javitt Jonathan C
Schedule 13D ownership disclosure
NRX PHARMACEUTICALS INC
Security class unavailable · CUSIP: 629444100
Event date: 2021-05-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 60.6600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950142-21-001848
- Form type
- SC 13D
- Filer
- Javitt Jonathan C
- CIK
- CIK 1303782
- Filed
- Jun 03, 2021
- Reporting period
- May 24, 2021
- Description
- Schedule 13D beneficial ownership